Bausch Health Cos EPS - Earnings per Share 2010-2024 | BHC

Bausch Health Cos eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Bausch Health Cos Annual EPS
2023 $-1.62
2022 $-0.62
2021 $-2.64
2020 $-1.58
2019 $-5.08
2018 $-11.81
2017 $6.83
2016 $-6.94
2015 $-0.85
2014 $2.58
2013 $-2.70
2012 $-0.38
2011 $0.49
2010 $-1.06
2009 $1.11
Bausch Health Cos Quarterly EPS
2024-09-30 $-0.23
2024-06-30 $0.03
2024-03-31 $-0.17
2023-12-31 $-0.11
2023-09-30 $-1.03
2023-06-30 $0.07
2023-03-31 $-0.55
2022-12-31 $-1.13
2022-09-30 $1.10
2022-06-30 $-0.40
2022-03-31 $-0.19
2021-12-31 $0.21
2021-09-30 $0.52
2021-06-30 $-1.66
2021-03-31 $-1.71
2020-12-31 $-0.43
2020-09-30 $0.20
2020-06-30 $-0.92
2020-03-31 $-0.43
2019-12-31 $-4.30
2019-09-30 $-0.14
2019-06-30 $-0.49
2019-03-31 $-0.15
2018-12-31 $-0.96
2018-09-30 $-1.00
2018-06-30 $-2.49
2018-03-31 $-7.36
2017-12-31 $1.46
2017-09-30 $3.69
2017-06-30 $-0.11
2017-03-31 $1.79
2016-12-31 $-1.49
2016-09-30 $-3.49
2016-06-30 $-0.88
2016-03-31 $-1.08
2015-12-31 $-1.12
2015-09-30 $0.14
2015-06-30 $-0.15
2015-03-31 $0.28
2014-12-31 $1.47
2014-09-30 $0.81
2014-06-30 $0.37
2014-03-31 $-0.07
2013-12-31 $0.28
2013-09-30 $-2.92
2013-06-30 $0.03
2013-03-31 $-0.09
2012-12-31 $-0.29
2012-09-30 $0.02
2012-06-30 $-0.07
2012-03-31 $-0.04
2011-12-31 $0.17
2011-09-30 $0.13
2011-06-30 $0.17
2011-03-31 $0.02
2010-12-31 $0.02
2010-09-30 $-1.27
2010-06-30 $0.21
2010-03-31 $-0.02
2009-12-31 $0.46
2009-09-30 $0.25
2009-06-30 $0.15
2009-03-31 $0.25
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00